Intelgenx Technologies Corp (IGXT)
0.1666
+0.02
(+11.09%)
USD |
OTCM |
Apr 25, 15:59
Intelgenx Technologies Total Assets (Quarterly): 8.282M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 8.282M |
| September 30, 2023 | 8.113M |
| June 30, 2023 | 7.824M |
| March 31, 2023 | 10.34M |
| December 31, 2022 | 9.19M |
| September 30, 2022 | 11.35M |
| June 30, 2022 | 14.19M |
| March 31, 2022 | 18.04M |
| December 31, 2021 | 17.90M |
| September 30, 2021 | 20.64M |
| June 30, 2021 | 20.42M |
| March 31, 2021 | 10.24M |
| December 31, 2020 | 11.12M |
| September 30, 2020 | 10.59M |
| June 30, 2020 | 11.57M |
| March 31, 2020 | 12.71M |
| December 31, 2019 | 11.02M |
| September 30, 2019 | 13.07M |
| June 30, 2019 | 15.81M |
| March 31, 2019 | 18.32M |
| December 31, 2018 | 20.02M |
| September 30, 2018 | 11.05M |
| June 30, 2018 | 12.09M |
| March 31, 2018 | 10.97M |
| December 31, 2017 | 13.15M |
| Date | Value |
|---|---|
| September 30, 2017 | 15.17M |
| June 30, 2017 | 10.56M |
| March 31, 2017 | 11.51M |
| December 31, 2016 | 12.79M |
| September 30, 2016 | 13.47M |
| June 30, 2016 | 8.735M |
| March 31, 2016 | 7.938M |
| December 31, 2015 | 8.916M |
| September 30, 2015 | 7.09M |
| June 30, 2015 | 5.561M |
| March 31, 2015 | 5.712M |
| December 31, 2014 | 6.284M |
| September 30, 2014 | 5.595M |
| June 30, 2014 | 6.344M |
| March 31, 2014 | 6.303M |
| December 31, 2013 | 6.217M |
| September 30, 2013 | 3.735M |
| June 30, 2013 | 3.61M |
| March 31, 2013 | 3.214M |
| December 31, 2012 | 4.159M |
| September 30, 2012 | 3.752M |
| June 30, 2012 | 4.255M |
| March 31, 2012 | 5.057M |
| December 31, 2011 | 4.57M |
| September 30, 2011 | 3.893M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
7.824M
Minimum
Jun 2023
20.64M
Maximum
Sep 2021
12.76M
Average
11.35M
Median
Sep 2022
Total Assets (Quarterly) Benchmarks
| Acasti Pharma Inc | 76.18M |
| Aurinia Pharmaceuticals Inc | 548.06M |
| Edesa Biotech Inc | 7.832M |
| Lexaria Bioscience Corp | 6.352M |
| Xenon Pharmaceuticals Inc | 964.80M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 20.53M |
| Shareholders Equity (Quarterly) | -12.25M |
| Debt to Equity Ratio | -1.216 |
| Current Ratio | 0.4085 |
| Net Debt Paydown Yield | -4.29% |